Investors

Insider Transactions

Date Name Title Type Shares Traded Price Range Sorted Descending
Aug 18, 2014 mccorkle douglas s Officer Automatic Sell 5,875 353.00
Aug 27, 2014 tessier-lavigne marc Director Sell 3,000 352.20
Aug 26, 2014 tessier-lavigne marc Director Disposition (Non Open Market) 200 351.62
Aug 26, 2014 vagelos p roy Officer Disposition (Non Open Market) 161,597 351.62
Aug 27, 2014 yancopoulos george Officer Disposition (Non Open Market) 5,426 351.33
Aug 18, 2014 aberman michael s Officer Automatic Sell 5,139 351.06
Aug 27, 2014 goldstein joseph l Director Sell 2,000 350.31
Aug 19, 2014 aberman michael s Officer Automatic Sell 3,611 350.00
Aug 15, 2014 brown michael s Director Automatic Sell 3,000 349.20
Aug 14, 2014 goldstein joseph l Director Sell 2,000 347.65
Feb 24, 2014 goldberg murray a Officer Automatic Sell 18,356 342.63
Aug 8, 2014 stahl neil Officer Sell 2,100 340.60 - 341.00
Aug 7, 2014 stahl neil Officer Sell 741 340.39 - 341.03
Aug 8, 2014 vagelos p roy Officer Sell 2,600 340.33
Aug 7, 2014 vagelos p roy Officer Disposition (Non Open Market) 142,651 340.12
Aug 11, 2014 vagelos p roy Officer Sell 9,372 340.02 - 341.02
Aug 13, 2014 vagelos p roy Officer Sell 8,028 340.01
Feb 21, 2014 gilman alfred g Director Automatic Sell 5,000 340.00
Aug 11, 2014 stahl neil Officer Sell 11,646 339.33 - 341.27
Feb 25, 2014 goldstein joseph l Director Sell 1,000 338.86
Showing 1-20 of 834 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42  See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)